Notice: This company has been marked as potentially delisted and may not be actively trading. Cellular Biomedicine Group (CBMG) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period US Cellular to Sell Certain Spectrum Licenses to AT&T For $1.02 BillionNovember 8, 2024 | msn.comUS Cellular agrees to sell $1 billion in assets to rival carrierNovember 8, 2024 | bizjournals.comIntra-Cellular bolsters Caplyta data with another Phase III winNovember 6, 2024 | finance.yahoo.comIntra-Cellular price target raised to $89 from $81 at JPMorganNovember 5, 2024 | markets.businessinsider.comIntra-Cellular announces results from Study 304 on lumateperoneNovember 5, 2024 | markets.businessinsider.comConsumer Cellular Announces New Barbie™ Flip PhoneNovember 1, 2024 | tmcnet.comIntra-Cellular price target raised to $135 from $130 at Cantor FitzgeraldNovember 1, 2024 | msn.comIntra-Cellular price target raised to $119 from $113 at CanaccordNovember 1, 2024 | markets.businessinsider.comUnited States Cellular Q3 Profit Tops Estimates; Raises 2024 Adj. EBITDA GuidanceNovember 1, 2024 | markets.businessinsider.comIntra-Cellular jumps on Q3 beat as Caplyta outlook brightensOctober 30, 2024 | msn.comIntra-Cellular Therapies: Buy Rating Affirmed Amid Strong Caplyta Sales and Strategic Growth ManagementOctober 30, 2024 | markets.businessinsider.comChang Gung Memorial Hospital Unveils Cellular Therapy: A Beacon of Hope for Cancer TreatmentOctober 21, 2024 | finance.yahoo.comUS Cellular to Sell Certain Spectrum Licenses to Verizon for $1 BillionOctober 18, 2024 | msn.comUS Cellular to sell select spectrum assets to Verizon for $1 billionOctober 18, 2024 | msn.comFresenius Kabi and Cellular Origins agree CGT manufacture automationOctober 17, 2024 | finance.yahoo.comNow Available in Canada: Tactacam's Defend Cellular Camera for Property SurveillanceOctober 16, 2024 | ca.finance.yahoo.comUS Cellular donates more than $40K to Boys and Girls Club of SiouxlandOctober 5, 2024 | msn.comCellular agriculture research manages to culture pork fat tissue on rye protein scaffoldsOctober 3, 2024 | msn.comPeakPTT Launches the PTT-284G: A Cost-Effective Push-To-Talk Over Cellular RadioOctober 2, 2024 | finance.yahoo.comConsumer Cellular Announces New IRIS Ally Medical Alert DeviceOctober 1, 2024 | finance.yahoo.comDo You Really Need a GPS + Cellular Apple Watch?September 27, 2024 | yahoo.comSave $49 on the Apple Watch Ultra 2 [GPS + Cellular] SmartwatchSeptember 24, 2024 | msn.comSave $110 on the Apple Watch Ultra [GPS + Cellular 49mm] Titanium Case with Midnight Ocean BandSeptember 21, 2024 | msn.comMillicom International Cellular Chairman Ramos to Step DownSeptember 19, 2024 | marketwatch.comInnovative Cellular Therapeutics Announces the Publication of Groundbreaking GCC19CART™ Study to Treat mCRC in JAMA OncologySeptember 19, 2024 | tmcnet.comUnited States Cellular (NYSE:USM) investors are up 5.3% in the past week, but earnings have declined over the last three yearsSeptember 17, 2024 | finance.yahoo.comConsumer Cellular Announces Appointment of Elizabeth Hunter as Chief Operations OfficerSeptember 11, 2024 | finance.yahoo.comToday’s deals: $129 Apple Watch Cellular, $750 Hisense 75-inch TV, $29 humidifier, $140 standing desk, moreSeptember 9, 2024 | yahoo.comPeaking Back In On Intra-Cellular TherapiesSeptember 4, 2024 | seekingalpha.comWireless, Wi-Fi, RFID & Cellular Industry Almanac 2025: Market Research, Statistics, Trends and Leading CompaniesAugust 23, 2024 | finance.yahoo.comCarematix Unveils Revolutionary Cellular Weight Scale with Advanced Weight Asymmetry TechnologyAugust 14, 2024 | finance.yahoo.comHCA Florida North Florida Hospital announces launch of new Blood Cancer and Bone Marrow Transplant and Cellular Therapy ProgramAugust 14, 2024 | msn.comIdea Cellular earnings preview: what to expectAugust 11, 2024 | markets.businessinsider.comStrong Buy: Intra-Cellular Therapies Poised for Growth with Caplyta and Expanding PipelineAugust 8, 2024 | markets.businessinsider.comEVP Of United States Cellular Makes $1.86M SaleAugust 8, 2024 | benzinga.comIntra-Cellular Therapies GAAP EPS of -$0.16 beats by $0.05, revenue of $161.3M beats by $3.42MAugust 7, 2024 | msn.comIntra-Cellular Therapies Q2 2024 Earnings PreviewAugust 6, 2024 | msn.comAmerican Society for Transplantation and Cellular Therapy Applauds FDA Approval of TECELRA(R) for Synovial Sarcoma TreatmentAugust 3, 2024 | finance.yahoo.comMillicom International Cellular misses top-line and bottom-line estimates; reaffirms FY24 outlookAugust 2, 2024 | msn.comConsumer Cellular Cell Phone Plans 2024July 31, 2024 | msn.comSix U.S. Senators Send Letter Objecting to $4.4 Billion T-Mobile-US Cellular DealJuly 23, 2024 | msn.comA Closer Look at 11 Analyst Recommendations For Intra-Cellular TherapiesJuly 22, 2024 | markets.businessinsider.comT-Mobile Swallows Up Most Of US Cellular For $4.4 BillionMay 29, 2024 | msn.comUS Cellular selling most of its assets to T-Mobile for $4.4 billionMay 29, 2024 | bizjournals.comT Mobile to acquire US Cellular for $4.4bnMay 29, 2024 | finance.yahoo.comUnited States Cellular Corporation's (NYSE:USM) Intrinsic Value Is Potentially 88% Above Its Share PriceMay 29, 2024 | finance.yahoo.comT-Mobile is set to buy US Cellular for $4.4billion - here is what it can mean for your serviceMay 29, 2024 | msn.comWhy T-Mobile Buying US Cellular Could Be A Disaster For Budget Cellphone PlansMay 28, 2024 | msn.comT-Mobile to buy almost all of US Cellular in deal worth $4.4 billionMay 28, 2024 | msn.comT-Mobile to buy US Cellular's wireless ops, plus slice of spectrum for $4.4BMay 28, 2024 | msn.com Get Cellular Biomedicine Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CBMG and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. CBMG Media Mentions By Week CBMG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CBMG News Sentiment▼0.000.47▲Average Medical News Sentiment CBMG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CBMG Articles This Week▼02▲CBMG Articles Average Week Get Cellular Biomedicine Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CBMG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BioCryst Pharmaceuticals News Novavax News Mesoblast News LENZ Therapeutics News Vir Biotechnology News Immatics News Relay Therapeutics News Anavex Life Sciences News Autolus Therapeutics News Replimune Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CBMG) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellular Biomedicine Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellular Biomedicine Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.